AHA GUIDELINES Bundle (free trial)

Supraventricular Tachycardia

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/600060

Contents of this Issue

Navigation

Page 21 of 33

Treatment Atrial Flutter Table 15. Acute Treatment of Atrial Flutter COR LOE Recommendations I A Oral dofetilide or IV ibutilide is useful for acute pharmacological cardioversion in patients with atrial flutter. I B-R IV or oral beta blockers, diltiazem, or verapamil are useful for acute rate control in patients with atrial flutter who are hemodynamically stable. I B-NR Elective synchronized cardioversion is indicated in stable patients with well-tolerated atrial flutter when a rhythm control strateg y is being pursued. I B-NR Synchronized cardioversion is recommended for acute treatment of patients with atrial flutter who are hemodynamically unstable and do not respond to pharmacological therapies. I C-LD Rapid atrial pacing is useful for acute conversion of atrial flutter in patients who have pacing wires in place as part of a permanent pacemaker or implantable cardioverter-defibrillator or for temporary atrial pacing aer cardiac surgery. I B-NR Acute antithrombotic therapy is recommended in patients with atrial flutter to align with recommended antithrombotic therapy for patients with AF. IIa B-R IV amiodarone can be useful for acute control of the ventricular rate (in the absence of pre-excitation) in patients with atrial flutter and systolic heart failure when beta blockers are contraindicated or ineffective. 20

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Supraventricular Tachycardia